
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16156569
[patent_doc_number] => 20200216517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => Integrin Antagonists
[patent_app_type] => utility
[patent_app_number] => 16/575009
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16575009
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/575009 | Integrin Antagonists | Sep 17, 2019 | Abandoned |
Array
(
[id] => 17460266
[patent_doc_number] => 20220073571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => PHOTORESPONSIVE PROTEIN AND UTILIZATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/276399
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276399 | Photoresponsive protein and utilization thereof | Sep 12, 2019 | Issued |
Array
(
[id] => 16930911
[patent_doc_number] => 20210196800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => DES-ACYL GHRELIN AND ANALOGS AS CANCER THERAPIES
[patent_app_type] => utility
[patent_app_number] => 17/271067
[patent_app_country] => US
[patent_app_date] => 2019-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/271067 | Des-acyl ghrelin and analogs as cancer therapies | Sep 2, 2019 | Issued |
Array
(
[id] => 16801275
[patent_doc_number] => 10996208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => Abaloparatide formulations and methods of testing, storing, modifying, and using same
[patent_app_type] => utility
[patent_app_number] => 16/553889
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 17171
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/553889 | Abaloparatide formulations and methods of testing, storing, modifying, and using same | Aug 27, 2019 | Issued |
Array
(
[id] => 15256411
[patent_doc_number] => 20190376939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => QUALITY CONTROL REAGENTS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/549769
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16549769
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/549769 | Quality control reagents and methods | Aug 22, 2019 | Issued |
Array
(
[id] => 15586463
[patent_doc_number] => 20200069766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING
[patent_app_type] => utility
[patent_app_number] => 16/543878
[patent_app_country] => US
[patent_app_date] => 2019-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16543878
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/543878 | COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING | Aug 18, 2019 | Abandoned |
Array
(
[id] => 15345221
[patent_doc_number] => 20200010502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => SYNTHESIS OF MULTIPHOSPHORYLATED PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/502616
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502616
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502616 | SYNTHESIS OF MULTIPHOSPHORYLATED PEPTIDES | Jul 2, 2019 | Abandoned |
Array
(
[id] => 15360947
[patent_doc_number] => 20200016238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => CARRIER-FREE BIOLOGICALLY-ACTIVE PROTEIN NANOSTRUCTURES
[patent_app_type] => utility
[patent_app_number] => 16/451996
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16451996
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/451996 | Carrier-free biologically-active protein nanostructures | Jun 24, 2019 | Issued |
Array
(
[id] => 17214499
[patent_doc_number] => 20210347836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => PEPTIDE FOR TREATING RETINITIS PIGMENTOSA
[patent_app_type] => utility
[patent_app_number] => 17/254115
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254115 | Peptide for treating retinitis pigmentosa | Jun 20, 2019 | Issued |
Array
(
[id] => 16336543
[patent_doc_number] => 10787487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Cell/tissue-specific cell-penetrating antibodies
[patent_app_type] => utility
[patent_app_number] => 16/447804
[patent_app_country] => US
[patent_app_date] => 2019-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 59
[patent_no_of_words] => 40967
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16447804
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/447804 | Cell/tissue-specific cell-penetrating antibodies | Jun 19, 2019 | Issued |
Array
(
[id] => 15290481
[patent_doc_number] => 20190388376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIAS
[patent_app_type] => utility
[patent_app_number] => 16/446374
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16446374
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/446374 | Compositions and methods for the treatment of hemoglobinopathies and thalassemias | Jun 18, 2019 | Issued |
Array
(
[id] => 17969350
[patent_doc_number] => 11486874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Methods for quantitation of insulin levels by mass spectrometry
[patent_app_type] => utility
[patent_app_number] => 16/442894
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 79
[patent_no_of_words] => 32281
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16442894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/442894 | Methods for quantitation of insulin levels by mass spectrometry | Jun 16, 2019 | Issued |
Array
(
[id] => 17236661
[patent_doc_number] => 11180533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Process for the preparation of Cetrorelix acetate
[patent_app_type] => utility
[patent_app_number] => 16/441238
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3546
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16441238
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/441238 | Process for the preparation of Cetrorelix acetate | Jun 13, 2019 | Issued |
Array
(
[id] => 15321091
[patent_doc_number] => 20200000875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => Injectable Self-assembling Antibacterial Peptide Hydrogels
[patent_app_type] => utility
[patent_app_number] => 16/438872
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438872
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438872 | Injectable self-assembling antibacterial peptide hydrogels | Jun 11, 2019 | Issued |
Array
(
[id] => 17620167
[patent_doc_number] => 11339205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Methods and compositions for the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 16/433438
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 14806
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433438
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433438 | Methods and compositions for the treatment of cancer | Jun 5, 2019 | Issued |
Array
(
[id] => 14963145
[patent_doc_number] => 20190309050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => FUSION PROTEIN SLIT2D2(C386S)-HSA AND USE THEREOF IN TREATMENT OF FIBROTIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/430984
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430984
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/430984 | Fusion protein Slit2D2(C386S)-HSA and use thereof in treatment of fibrotic diseases | Jun 3, 2019 | Issued |
Array
(
[id] => 16215115
[patent_doc_number] => 10730913
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-08-04
[patent_title] => Antimicrobial analogues of gramicidin S
[patent_app_type] => utility
[patent_app_number] => 16/428477
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 12603
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16428477
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/428477 | Antimicrobial analogues of gramicidin S | May 30, 2019 | Issued |
Array
(
[id] => 16230547
[patent_doc_number] => 10738085
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-08-11
[patent_title] => Antimicrobial analogues of Gramicidin S
[patent_app_type] => utility
[patent_app_number] => 16/428469
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 12606
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16428469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/428469 | Antimicrobial analogues of Gramicidin S | May 30, 2019 | Issued |
Array
(
[id] => 15206457
[patent_doc_number] => 20190365915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => MODIFIED SELF-IMMOLATING MOIETIES FOR USE IN PRODRUGS AND CONJUGATES AND METHODS OF USING AND MAKING
[patent_app_type] => utility
[patent_app_number] => 16/425596
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16425596
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/425596 | Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making | May 28, 2019 | Issued |
Array
(
[id] => 15574075
[patent_doc_number] => 10577404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Polypeptide derivatives from grass carp interferon and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/419944
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 7
[patent_no_of_words] => 3605
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16419944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/419944 | Polypeptide derivatives from grass carp interferon and application thereof | May 21, 2019 | Issued |